e-learning
resources
Berlin 2001
Wednesday 26.09.2001
Cardiovascular pathophysiology in OSA
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cardiovascular and metabolic consequences of obstructive sleep apnoea
S. R. Coughlin, L. Mawdsley, J. A. Mugarza, J. P. H. Wilding, P. M. A. Calverley (Liverpool, United Kingdom)
Source:
Annual Congress 2001 - Cardiovascular pathophysiology in OSA
Session:
Cardiovascular pathophysiology in OSA
Session type:
Oral Presentation
Number:
3498
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. R. Coughlin, L. Mawdsley, J. A. Mugarza, J. P. H. Wilding, P. M. A. Calverley (Liverpool, United Kingdom). Cardiovascular and metabolic consequences of obstructive sleep apnoea. Eur Respir J 2001; 16: Suppl. 31, 3498
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Cardiovascular morbidity in obstructive sleep apnoea
Source: Annual Congress 2009 - PG5 Core Curriculum Postgraduate Course: Obstructive sleep apnoea – current pathophysiological, clinical and therapeutic concepts
Year: 2009
The metabolic consequences of obstructive sleep apnoea in children
Source: Breathe 2009; 6: 111-114
Year: 2009
Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients
Source: Eur Respir J 2008; 31: 223-225
Year: 2008
Cardiovascular morbidity and obstructive sleep apnoea in children
Source: Annual Congress 2009 - Current developments in sleep-disordered breathing in children
Year: 2009
Pathophysiological consequences of obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease
Source: Eur Respir J 2013; 41: 616-620
Year: 2013
Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007
Asthma, obesity, metabolic dysfunction and obstructive sleep apnoea
Source: International Congress 2019 – State of the art session: Sleep and breathing disorders
Year: 2019
Obstructive sleep apnea and specific cardiovascular outcomes
Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care
Year: 2018
Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017
Obstructive sleep apnoea and metabolic impairment in severe obesity
Source: Eur Respir J 2011; 38: 1089-1097
Year: 2011
The puzzle of metabolic effects of obstructive sleep apnoea in children
Source: Eur Respir J 2016; 47: 1050-1053
Year: 2016
Association between obstructive sleep apnea hypopnea and metabolic syndromes
Source: Eur Respir J 2004; 24: Suppl. 48, 692s
Year: 2004
The impact of obstructive sleep apnea syndrome on cardiovascular system in children
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011
Cardiovascular comorbidity by clinical phenotypes of obstructive sleep apnea and sleeping hours
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020
Hypertension and obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
Obstructive sleep apnoea and COPD
Source: Eur Respir Mon 2013; 59: 135-143
Year: 2013
The economic consequences of snoring, obstructive sleep apnea and obesity hypoventilation syndrome
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Pulmonary hypertension and obstructive sleep apnea syndrome -Marmara Universitypediatric sleep laboratory experience
Source: Virtual Congress 2020 – Respiratory physiology and sleep: what is new?
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept